Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer

PURPOSE: The aim of this study was to assess whether nebivolol treatment could have beneficial effects in the prevention of anthracyclines-induced cardiotoxicity. PATIENTS AND METHODS: Our prospective study included 60 women, mean age 52.6±13 years, with HER2 negative breast cancer, scheduled to und...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Manag Res
Päätekijät: Cochera, Flavia, Dinca, Daniel, Bordejevic, Diana Aurora, Citu, Ioana Mihaela, Mavrea, Adelina Marioara, Andor, Minodora, Trofenciuc, Mihai, Tomescu, Mirela Cleopatra
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2018
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6053261/
https://ncbi.nlm.nih.gov/pubmed/30038521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S166481
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia